200 followers
Comment on Charles-Schoeman C (2016): Efficacy and safety of tofacitinib following inadequate response to conven https://t.co/n4650DKXeH
Comment on Charles-Schoeman C (2016): Efficacy and safety of tofacitinib following inadequate response to conven https://t.co/n4650DKXeH
RT @ARD_BMJ: Open Access: Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or bio... https://t.co…
RT @ARD_BMJ: Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disea... https://t.co…
Efficacy and safety of tofacitinib following inadequate response conventional synthetic or biological dmard #rheum https://t.co/ZZ9m6wsfaD